Selenium and glutamine supplements: where are we heading? A critical care perspective.
OBJECTIVE
There is considerable interest in glutamine and selenium in critical care as both offer the potential to enhance host defences, through different but complimentary mechanisms and may reduce subsequent infections and mortality. The SIGNET trial (randomized controlled factorial trial) is the largest, critical care study of both supplements. The data have been presented publicly, but the data are not published or available for review and will therefore not be discussed fully in this update. In the present review I will explore the recently available (past 1-2 years) published literature.


RESULTS
The current literature demonstrates that there are currently insufficient data to enable confident recommendations on the optimal route, timing, duration and dosage of each of these nutritional supplements. The pending results of SIGNET, the largest critical care trial of parenteral nutrition supplemented by glutamine and or selenium promises to clarify some of the current ambiguities and inform future practice.


CONCLUSIONS
To be able to confidently establish or refute the hypothesis that either glutamine or selenium alone or in combination improves outcome in critical care requires a well designed prospective randomized controlled trial. To design such a trial we require the optimal dose and duration of the nutritional supplement (balancing efficacy and toxicity, ease of administration and cost) and then conduct an adequately powered trial. Such a trial is still lacking for these two agents. There are some supportive data for selenium but the case is less strong for parenteral glutamine and weakest for enteral glutamine.
Andrews
Peter J D
PJ
Department of Anaesthesia, Critical Care and Pain Management, University of Edinburgh, Edinburgh, UK. p.andrews@ed.ac.uk
D003422:Critical Care / Q000379:methods*; D019587:Dietary Supplements; D005973:Glutamine / Q000008:administration & dosage*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D009751:Nutritional Requirements; D018529:Nutritional Support; D012643:Selenium / Q000008:administration & dosage*; D014131:Trace Elements / Q000008:administration & dosage*
D007155:Immunologic Factors; D014131:Trace Elements; D005973:Glutamine; D012643:Selenium